Recombinant human erythropoietin in the treatment of cancer-related anaemia

European Journal of Haematology

Volumn 58, Issue 4, 1997, Pages 251-256

  Kasper, C ^a,b   Terhaar, A ^a   Fossa A ^a   Welt, A ^a   Seeber, S ^a   Nowrousian, M R ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

anaemia of chronic disease; cancer related anaemia; predictor of response; rhEPO

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; CANCER; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL;

EID: 0030970328     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1997.tb01663.x     Document Type: Article

References (24)

1. CARTWRIGHT GE. The anaemia of chronic disorders. Semin Hematol 1966: 3: 351-375.
2. MEANS RT, KRANTZ SB. Progress in understanding the pathogenesis of the anaemia of chronic disease. Blood 1992: 80: 1639-1647.
3. MILLER CB, JONES RJ, PIANTADOSI S, ABELOFF MD, SPIVAK JL. Decreased erythropoietin response in patients with the anaemia of cancer. N Engl J Med 1990: 322: 1689-1692.
4. FAQUIN WC, SCHNEIDER TJ, GOLDBERG MA. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 1992: 79: 1987-1994.
5. SKILLINGS JR, SRIDHAR FG, WONG C, PADDOCK L. The frequency of red cell transfusion for anaemia in patients receiving chemotherapy. A retrospective cohort study. Am J Clin Oncol 1993: 16: 22-25.
6. BORDIN JO, HEDDLE NM, BLAJCHMAN MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994: 84: 1703-1721.
7. WELCH HG, MEEHAN KR, GOODNOUGH LT. Prudent strategies for elective red blood cell transfusion. Ann Intern Med 1992: 116: 393-402.
8. BURROWS L, TARTTER P. Effect of blood transfusions on colonie malignancy recurrence rate. Lancet 1982: ii: 662.
9. BUSCH OR, HOP WC, HOYNCK VAN PAPENDRECHT MA, MARQUET RL, JEEKEL J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993: 328: 1372-1376.
10. ESCHBACH JW, EGRIE JC, DOWNING MR, BROWNE JK, ADAMSON JW. Correction of the anaemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med 1987: 316: 73-78.
11. WINEARLS CG, OLIVER DO, PIPPARD MJ, REID C, DOWNING MR, COTES PM. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet 1986: 2: 1175-1178.
12. BAER AN, DESSYPRIS EN, GOLDWASSER E, KRANTZ SB. Blunted erythropoietin response to anaemia in rheumatoid arthritis. Br J Haematol 1987: 66: 559-564.
13. SPIVAK JL, BARNES DC, FUCHS E, QUINN TC. Serum immunoreactive erythropoietin in HIV-infected patients. JAMA 1989: 261: 3104-3107.
14. ABELS R. Erythropoietin for anaemia in cancer patients. Eur J Cancer 1993: 29A (S2): 2-8.
15. CASE DC, BUKOWSKI RM, CAREY RW, et al. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy. J Natl Cancer Inst 1993: 85: 801-806.
16. CAZZOLA M, PONCHIO L, BEGUIN Y, et al. Subcutaneous erythropoietin for treatment of refractory anaemia in hematologic disorders. Results of a phase I/II clinical trial. Blood 1992: 79: 29-37.
17. CAZZOLA M, MESSINGER D, BATTISTEL V, et al. Recombinant human erythropoietin in the anaemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response. Blood 1995: 86: 4446-4453.
18. LUDWIG H, FRITZ E, KOTZMANN H, HÖCKER P, GISSLINGER H, BARNAS U. Erythropoietin treatment of anemia associated with multiple myeloma. N Engl J Med 1990: 322: 1693-1699.
19. LUDWIG H, FRITZ E, LEITGEB C, KRAINER M, KÜHRER I, SAGASTER P, UMEK H. Erythropoietin treatment for chronic anaemia of selected hematological malignancies and solid tumours. Ann Oncol 1993: 4: 161-167.
20. OSTER W, HERRMANN F, GAMM H, ZEILE G, et al. Erythropoietin for the treatment of anaemia of malignancy associated with neoplastic bone marrow infiltration. J Clin Oncol 1990: 8: 956-962.
21. PLATANIAS LC, MILLER CB, MICK R, et al. Treatment of chemotherapy-induced anaemia with recombinant human erythropoietin in cancer patients. J Clin Oncol 1991: 9: 2021-2026.
22. HELLSTRÖM-LINDBERG E. Efficacy of erythropoietin in myelodysplastic syndromes: a meta-analysis of 205 patients from 17 studies. Br J Haematol 1995: 89: 67-71.
23. HENRY D, ABELS R, LARHOLT K. Prediction of response to recombinant human erythropoietin (r-HuEPO/epoetin-alpha) therapy in cancer patients (letter, comment). Blood 1995: 85: 1676-1678.
24. LUDWIG H, FRITZ E, LEITGEB C, PECHERSTORFER M, SAMONIGG H, SCHUSTER J. Prediction of response to erythropoietin treatment in chronic anaemia of cancer. Blood 1994: 84: 1056-1063.